FMP

FMP

Enter

GMED - Globus Medical, Inc.

photo-url-https://images.financialmodelingprep.com/symbol/GMED.png

Globus Medical, Inc.

GMED

NYSE

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

90.8 USD

0.33 (0.363%)

Latest GMED News

Zacks Investment Research

Aug 22, 2024

Globus Medical's (GMED) Lateral Interbody Portfolio Gets New Launch

Globus Medical's (GMED) lateral interbody portfolio gets its first commercial product launch with ADIRA XLIF Plate System.

Read More

Zacks Investment Research

Aug 9, 2024

Here's Why Globus Medical (GMED) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read More

Zacks Investment Research

Aug 8, 2024

Here's Why Globus Medical (GMED) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read More

Zacks Investment Research

Aug 7, 2024

Globus Medical (GMED) Q2 Earnings Top Estimates, '24 View Up

Globus Medical (GMED) delivers massive sales and earnings growth in the second quarter of 2024. However, margins contract.

Read More

Seeking Alpha

Aug 6, 2024

Globus Medical, Inc. (GMED) Q2 2024 Earnings Call Transcript

Globus Medical, Inc. (NYSE:GMED ) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Brian Kearns - SVP, Business Development and IR Daniel Scavilla - President and CEO Keith Pfeil - COO and CFO Conference Call Participants Matthew Miksic - Barclays Vikramjeet Chopra - Wells Fargo Shagun Singh - RBC CM Steve Lichtman - Oppenheimer David Saxon - Needham & Company Matthew O'Brien - Piper Sandler Jason Wittes - ROTH Matthew Blackman - Stifel Ryan Zimmerman - BTIG Ravi M...

Read More

Zacks Investment Research

Aug 6, 2024

Globus Medical (GMED) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Read More

Zacks Investment Research

Aug 6, 2024

Globus Medical (GMED) Q2 Earnings and Revenues Beat Estimates

Globus Medical (GMED) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.63 per share a year ago.

Read More

Zacks Investment Research

Jul 19, 2024

Globus Medical (GMED) Global Sales, Innovation Aid Growth

In line with the company's business strategy to focus on its integrated product development, Globus Medical (GMED) is consistently making efforts in research and development.

Read More

Zacks Investment Research

Jul 18, 2024

Globus Medical (GMED) Gets FDA Nod for ExcelsiusFlex, ACTIFY 3D

Globus Medical (GMED) gets the FDA 510(k) clearance for its ExcelsiusFlex with Total Knee Arthroplasty application and ACTIFY 3D Total Knee System.

Read More

GlobeNewsWire

Jul 16, 2024

Globus Medical Schedules Second Quarter Earnings Release and Conference Call

AUDUBON, Pa., July 16, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2024 after the market close on Tuesday, August 6, 2024. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.

Read More
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep